ArticlePloS one2025
3D-MRI analysis of cartilage thickness changes after PRP injection in medial knee osteoarthritis: A preliminary report.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Mechanistic Insights and Real-World Evidence of Autologous Protein Solution (APS) in Clinical Use.International journal of molecular sciences · 2025Trial
- Advances in cartilage imaging techniques.Nature reviews. Rheumatology · 2026Review
- 27-Week avocado-soybean unsaponifiables treatment in a knee osteoarthritis rabbit model: histomorphometric assessment of potential disease-modifying effects.Frontiers in veterinary science · 2026Article
- Platelet-rich plasma in cartilage repair: biological mechanisms and clinical perspectives.Frontiers in sports and active living · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The regenerative effect of platelet-rich plasma injection on cartilage in knee osteoarthritis remains controversial. The purpose of this study was to use our recently developed 3D-MRI evaluation system to examine in detail the changes in cartilage thickness occurring six months after platelet-rich plasma injection. This study included 21 knees from 16 patients with medial knee osteoarthritis. An autologous protein solution (APS) was injected as platelet-rich plasma, and magnetic resonance imaging scans were taken before and six months after the injection. Cartilage thickness was quantified in seven regions using SYNAPSE 3D. Based on previous studies, the measurement error was set at 0.1 mm. The proportion of knees in which cartilage thickness increased (>0.1 mm) was highest in the anteromedial femoral region (43%); followed by the anterolateral femoral and lateral tibial regions (24%); the posterolateral femoral, patellar, and medial tibial regions (19%); and lowest in the posteromedial femoral region (14%). Notably, in the posteromedial femoral and medial tibial regions, which are primarily affected by medial osteoarthritis, less than 20% of the knees showed increased cartilage thickness. Our findings suggest that while platelet-rich plasma injection may have a positive effect on cartilage thickness in certain regions of the knee, its impact on the regions most affected by medial osteoarthritis appears limited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.